Millennium Biotechnologies Group, Inc. (Millennium) is engages in the research, development and marketing of specialized nutritional supplements as an adjunct to medical treatments for select medical conditions, as well as for athletes. The Company’s marketed products are targeted toward immuno-compromised individuals undergoing medical treatment for diseases, such as cancer, as well as individuals living with human immunodeficiency virus (HIV)/acquired immune deficiency syndrome (AIDS) and wound healing and post-surgical healing and geriatric among other conditions. Millennium also is marketing the Surgex product line to elite athletes. Millennium’s manufactures and markets five product lines and 21 stock keeping units (SKU’s) to seven separate target markets.